Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000881984 | SCV001025192 | likely benign | not provided | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000881984 | SCV004151309 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ERBB4: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV000881984 | SCV005258289 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001580120 | SCV001809755 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000881984 | SCV001964716 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003930559 | SCV004740673 | benign | ERBB4-related disorder | 2022-12-22 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |